Immix Biopharma IMMX
NASDAQ IMMX
$8.35 -0.16 (-1.88%)
At close: Oct 22, 2026 · 4:00 PM EDT

Immix Biopharma (IMMX) Interest Expenses (2021 - 2022)

Updated

Immix Biopharma's Interest Expenses was $497.00 in FY2022, down 99.7% from $179,853 in FY2021.

Analysis

Immix Biopharma (IMMX) Interest Expenses (2021 - 2022) Analysis & Trends

  • Per Business Quant data, Interest Expenses in earlier years was $179,853 in FY2021 (+76.4%) and $101,976 in FY2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int Expense (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn -
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 217.00 Mn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn -
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 462.00 Mn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 435.00 Mn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 673.00 Mn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 247.00 Mn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn -
10 Immix Biopharma 531.85 Mn 299.75 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 109.00
Mar 31, 2022 388.00
Dec 31, 2021 44,507.00
Sep 30, 2021 53,937.00
Jun 30, 2021 53,865.00
Mar 31, 2021 27,544.00
API Access

Immix Biopharma Interest Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-expenses&ticker=IMMX&period=max&api_key=YOUR_API_KEY